LOADING
Comparing Merck & Company (MRK) and Salesforce Inc (CRM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | CRM |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $295.4B | -- |
| P/E Ratio | 33.7 | -- |
| Forward P/E | 23.6 | -- |
| PEG Ratio | 5.56 | -- |
| EPS | $3.55 | -- |
| Revenue Growth (YoY) | 4.9% | -- |
| Profit Margin | 13.6% | -- |
| Return on Equity | 18.9% | -- |
| Dividend Yield | 2.84% | -- |
| Beta | 0.22 | -- |
| 52-Week High | $123.33 | -- |
| 52-Week Low | $74.18 | -- |
| Volume | -- | -- |